Integrated Ambulatory Blood Pressure Monitoring and Pulse Wave Analysis to underline I.E.M.'s technology leadership

Stolberg 15 December 2008I.E.M. has launched its integrated Pulse Wave Analysis (PWA) Solution as an upgrade to the well proven ambulatory 24-hour blood pressure monitoring (ABPM) system Mobil-O-Graph NG. The new feature has been developed together with the Austrian Research Center (ARC) and once more underlines I.E.M.'s claim as technology expert in the field of hypertension management and virtual hypertension clinic.


For the accurate diagnosis of hypertension, measurements of blood pressure as well as the analysis of pulse wave are crucial. As a first result of the co-operation with the Austrian Research Center - Austria's largest research organisation for applied research - I.E.M. integrated the new pulse wave analysis algorithms to the well-proven ambulatory blood pressure monitor device Mobile-O-Graph.

Until now pulse wave devices were previously reserved exclusively for hospitals due to their high cost. Thanks to the new I.E.M. technology, PWA cost has been dramatically reduced to make this diagnostic available to cardiologists, internists and general physicians and thus a large number of patients as a standard diagnostic procedure. The I.E.M. technology offers the first complete suite of hypertension management tools worldwide. The virtual hypertension clinic includes PWA, ABPM, Tele-ABPM and Office-BPM.

Previously it was assumed that the blood pressure on the arm reflects the pressure in other parts of the body. But studies show that the pressure measurement to the aorta by the simple standard method of measuring blood pressure, supplemented by the pulse wave, is a more accurate and more appropriate method to find a better prognosis to therapy and control hypertension patients. At the European High Congress in Milan 2007 the analysis of pulse wave was strongly recommended to manage arterial hypertension and early diagnosis of arterial system damage.

The implementation of Pulse Wave Analysis in the standard diagnostic procedures for hypertensive patients is the logical result of the outcome of the Conduit Artery Functional Evaluation (CAFE) study. Despite similar brachial systolic blood pressure within the study results, amlodipine based treatment was more effective than atenolol based treatment at lowering central aortic systolic blood pressure and central aortic pulse pressure, which were proven to closely correlate with CV events and procedures of study participants.

All I.E.M. devices provide the collected data via the communication standard Bluetooth to a mobile phone or modem without any user interaction. In accordance to the high European standards of data security and encryption the information is transferred automatically via the mobile phone network to an electronic patient record. Patient and physician have password protected access to the information. Thresholds for status alerts can be easily set by the physician. Doctor and patient receive status via e-mail, facsimile, letter or text message (SMS).

I.E.M. GmbH, founded 1993 in Stolberg, Germany, is a worldwide recognized specialist for blood pressure management, sensor and communication technology, e-health databases and electronic patient records. The product range focus is on medical monitoring equipment for weight, long term and mobile blood pressure measurement. I.E.M. co-operates with patient care givers and health insurance companies in several countries.

The latest product, a PWA analysis solution was jointly developed with the Austrian Research Center in Vienna. More then 40.000 customers worldwide trust in I.E.M. products and solutions. I.E.M. products are distributed in the United States by VitalStream Health.

Source: I.E.M.

[Medical IT News][Calendar][Virtual Medical Worlds Community][News on Advanced IT]